Lung Cancer Screening Rates Remain Low in the U.S., Especially in the South

MedPage Today June 10, 2024
Mike Bassett

— But one study showed that patient navigation added to usual care may increase uptake

Fewer than one in five people eligible for lung cancer screening reported being up to date with screening in 2022, though patient navigation added to usual care could be a way of increasing these rates, according to two studies published in JAMA Internal Medicine.

Among nearly 26,000 respondents in a nationwide cross-sectional study, the overall prevalence of up-to-date lung cancer screening was 18.1%, but varied across states (range 9.7% to 31%), with relatively lower rates in Southern states that have a high lung cancer mortality burden, noted Priti Bandi, PhD, of the American Cancer Society, and colleagues.

“The largest disparities in [up-to-date lung cancer screening]...

Today's Sponsors

Today's Sponsor